Aarey Drugs & Pharmaceuticals Limited

Company Profile

Aarey Drugs & Pharmaceuticals Limited had its IPO on under the ticker symbol AAREYDRUGS.

The company operates in the sector and industry. Aarey Drugs & Pharmaceuticals Limited has a staff strength of 0 employees.

Stock update

Shares of Aarey Drugs & Pharmaceuticals Limited opened at 28.25 at the start of the last trading session i.e. 2023-05-28.

The stocks traded within a range of 28 - 29, and closed at 28.8.

This is a +2.49% increase from the previous day's closing price.

A total volume of 26,834 shares were traded at the close of the day’s session.

In the last one week, shares of Aarey Drugs & Pharmaceuticals Limited have slipped by -0.52%.

Aarey Drugs & Pharmaceuticals Limited's Key Ratios

Aarey Drugs & Pharmaceuticals Limited has a market cap of 0, indicating a price to book ratio of and a price to sales ratio of .

In the last 12-months Aarey Drugs & Pharmaceuticals Limited’s revenue was 0 with a gross profit of 0 and an EBITDA of 0. The EBITDA ratio measures Aarey Drugs & Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aarey Drugs & Pharmaceuticals Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q0.33333333333333, Aarey Drugs & Pharmaceuticals Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Aarey Drugs & Pharmaceuticals Limited’s PE and PEG Ratio

Forward PE

Trailing PE

PEG

Its diluted EPS in the last 12-months stands at per share while it has a forward price to earnings multiple of and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aarey Drugs & Pharmaceuticals Limited’s profitability.

Aarey Drugs & Pharmaceuticals Limited stock is trading at a EV to sales ratio of and a EV to EBITDA ratio of . Its price to sales ratio in the trailing 12-months stood at .

Aarey Drugs & Pharmaceuticals Limited stock pays annual dividends of per share, indicating a yield of and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

0

Total Liabilities

0

Operating Cash Flow

0

Capital Expenditure

0

Dividend Payout Ratio

0%

Aarey Drugs & Pharmaceuticals Limited ended 1970 with 0 in total assets and 0 in total liabilities. Its intangible assets were valued at 0 while shareholder equity stood at 0.

Aarey Drugs & Pharmaceuticals Limited ended 1970 with 0 in deferred long-term liabilities, 0 in other current liabilities, in common stock, 0 in retained earnings and 0 in goodwill. Its cash balance stood at 0 and cash and short-term investments were 0. The company’s total short-term debt was 0 while long-term debt stood at 0.

Aarey Drugs & Pharmaceuticals Limited’s total current assets stands at 0 while long-term investments were 0 and short-term investments were 0. Its net receivables were 0 compared to accounts payable of 0 and inventory worth 0.

In 1970, Aarey Drugs & Pharmaceuticals Limited's operating cash flow was 0 while its capital expenditure stood at 0.

Comparatively, Aarey Drugs & Pharmaceuticals Limited paid 0 in dividends in 1970.

Other key metrics

Current Trading Price

28.8

52-Week High

52-Week Low

Analyst Target Price

Aarey Drugs & Pharmaceuticals Limited stock is currently trading at 28.8 per share. It touched a 52-week high of and a 52-week low of . Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was 27.05 and 200-day moving average was 34.32 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.